Echosens has a collection of Market Access Tools to help healthcare providers make informed decisions regarding the use its products. If you have questions regarding Reimbursement, or need more information, please contact the Echosens Market Access Hotline. Dedicated professionals are available to help answer your questions.
FibroScan® Market Access Guide
Additionally, other resources are available to keep you well-informed of the latest market access trends and changes. Please access some of our materials below.
Current Market Access webinars are listed below. To view the webinar, click on the presentation of interest to register.
CPT® code 76981 is reported for ultrasound imaging-based elastographic (USE) evaluation of the parenchyma of an organ for the assessment of the degree of stiffness or fibrosis. USE does not include the work of diagnostic ultrasound, and if a diagnostic ultrasound is ordered, medically necessary, and performed on the same or another organ during the same session of ultrasound elastography, it may be separately reported. When imaging guidance is used to perform USE on any organ, CPT® code 76981 should be utilized. When performing USE of the spleen with the FibroScan® Expert 630 device, CPT® code 76981 should be utilized. If performing USE on both the liver and the spleen during the same session, 76981 should be reported twice and documentation should clearly indicate two separate elastography exams were conducted.
Yes. When E/M services are provided on the same day as a FibroScan® exam, the additional service must be added to the claim form. CPT® instructs appending the 25 modifier to the E/M service code to confirm that distinct services were performed.
Yes. A FibroScan® exam can be conducted before or after a diagnostic ultrasound. The codes are separately reportable.